CAMZYOS Trademark

Trademark Overview

On Thursday, November 14, 2019, a trademark application was filed for CAMZYOS with the United States Patent and Trademark Office. The USPTO has given the CAMZYOS trademark a serial number of 88693134. The federal status of this trademark filing is REGISTERED as of Tuesday, August 2, 2022. This trademark is owned by MyoKardia, Inc.. The CAMZYOS trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for prevention and treatment of cardiovascular diseases and disorders
camzyos

General Information

Serial Number88693134
Word MarkCAMZYOS
Filing DateThursday, November 14, 2019
Status700 - REGISTERED
Status DateTuesday, August 2, 2022
Registration Number6809373
Registration DateTuesday, August 2, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 31, 2020

Trademark Statements

Goods and Servicespharmaceutical preparations for prevention and treatment of cardiovascular diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 26, 2019
Primary Code005
First Use Anywhere DateTuesday, May 3, 2022
First Use In Commerce DateTuesday, May 3, 2022

Trademark Owner History

Party NameMyoKardia, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrisbane, CA 94005
Party NameMyoKardia, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrisbane, CA 94005
Party NameMyoKardia, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Tuesday, August 2, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 2, 2022REGISTERED-PRINCIPAL REGISTER
Saturday, June 25, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, June 24, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, June 13, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, May 25, 2022USE AMENDMENT FILED
Monday, June 13, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 25, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, November 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 5, 2021SOU EXTENSION 3 GRANTED
Friday, November 5, 2021SOU EXTENSION 3 FILED
Friday, November 5, 2021TEAS EXTENSION RECEIVED
Wednesday, March 31, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 29, 2021SOU EXTENSION 2 GRANTED
Monday, March 29, 2021SOU EXTENSION 2 FILED
Monday, March 29, 2021TEAS EXTENSION RECEIVED
Saturday, October 24, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 22, 2020SOU EXTENSION 1 GRANTED
Thursday, October 22, 2020SOU EXTENSION 1 FILED
Thursday, October 22, 2020TEAS EXTENSION RECEIVED
Tuesday, May 26, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, April 3, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 3, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 3, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 31, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 31, 2020PUBLISHED FOR OPPOSITION
Wednesday, March 11, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 21, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 19, 2020ASSIGNED TO EXAMINER
Monday, February 10, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 26, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 18, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

camzyos diseases disorders cardiovascular treatment preparations prevention pharmaceutical